Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pau Serra

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Immunology|February 11, 2018
Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseasesPau Serra, Pere Santamaria
Clinical Immunology (Orlando, Fla.)|February 24, 2015
Nanoparticle-based autoimmune disease therapyPau Serra, Pere Santamaria
Trends in Immunology|November 23, 2005
To 'B' regulated: B cells as members of the regulatory workforcePau Serra, Pere Santamaria
Frontiers in Immunology|February 12, 2021
Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and DiseasesPau Serra, Pere Santamaria
Nature Biotechnology|February 27, 2019
Antigen-specific therapeutic approaches for autoimmunityPau Serra, Pere Santamaria
Diabetes|January 29, 2002
T-cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetesShari Thiessen, Pau Serra, Abdelaziz Amrani, et al.
Frontiers in Immunology|September 16, 2021
Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell ReceptorDaniel Parras, Patricia Solé, Thomas Delong, et al.
Frontiers in Immunology|August 15, 2022
Structural plasticity in I-A<sup>g7</sup> links autoreactivity to hybrid insulin peptides in type I diabetesElena Erausquin, Pau Serra, Daniel Parras, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigensJun Yamanouchi, Joan Verdaguer, Bingye Han, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2013
Dendritic cell-dependent in vivo generation of autoregulatory T cells by antidiabetogenic MHC class IISue Tsai, Pau Serra, Xavier Clemente-Casares, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Immunology|February 11, 2018
Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseasesPau Serra, Pere Santamaria
Clinical Immunology (Orlando, Fla.)|February 24, 2015
Nanoparticle-based autoimmune disease therapyPau Serra, Pere Santamaria
Trends in Immunology|November 23, 2005
To 'B' regulated: B cells as members of the regulatory workforcePau Serra, Pere Santamaria
Frontiers in Immunology|February 12, 2021
Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and DiseasesPau Serra, Pere Santamaria
Nature Biotechnology|February 27, 2019
Antigen-specific therapeutic approaches for autoimmunityPau Serra, Pere Santamaria
Diabetes|January 29, 2002
T-cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetesShari Thiessen, Pau Serra, Abdelaziz Amrani, et al.
Frontiers in Immunology|September 16, 2021
Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell ReceptorDaniel Parras, Patricia Solé, Thomas Delong, et al.
Frontiers in Immunology|August 15, 2022
Structural plasticity in I-A<sup>g7</sup> links autoreactivity to hybrid insulin peptides in type I diabetesElena Erausquin, Pau Serra, Daniel Parras, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigensJun Yamanouchi, Joan Verdaguer, Bingye Han, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2013
Dendritic cell-dependent in vivo generation of autoregulatory T cells by antidiabetogenic MHC class IISue Tsai, Pau Serra, Xavier Clemente-Casares, et al.
Pageof 6